Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/24708917
Conclusion of this study
In line with our hypothesis, the concentration of sFlt-1 was significantly lower at 35 weeks in the Se-treated group than in the placebo group in participants in the lowest quartile of Se status at baseline (P= 0·039). None of the secondary outcome measures was significantly affected by treatment. The present finding that Se supplementation has the potential to reduce the risk of pre-eclampsia in pregnant women of low Se status needs to be validated in an adequately powered trial.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study